(NASDAQ)

36.93

-0.80 (-2.11%)

After Hours: 37.03 +0.1050 (+0.28%)

Volume (24h)	Market Cap.	Day Range	52w Range
6.54M	6.91B	36.68 - 40.77	2.20 - 40.77

Jan-13-21 12:19PM	Pacific Biosciences Reaches Our Price Target: Now What?TheStreet.com
11:15AM	Pacific Biosciences (PACB) Releases Preliminary Q4 RevenuesZacks
Jan-13-21 08:02AM	Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing PlatformGlobeNewswire
Jan-12-21 06:26AM	Pacific Biosciences Grants Equity Incentive Awards to New EmployeesGlobeNewswire
Jan-11-21 07:45AM	Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 RevenueGlobeNewswire
Jan-08-21 03:16AM	SoftBank Takes Stake in DNA Firm Pacific BiosciencesBloomberg
08:45AM	Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial OfficerGlobeNewswire
Jan-08-21 08:00AM	Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research InitiativeGlobeNewswire
Jan-07-21 09:13AM	3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021Zacks
Jan-01-21 01:31AM	Calculating The Fair Value Of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Simply Wall St.
Dec-31-20 05:00AM	The Best Stock Picker of 2020 Wins With Disruptive DNABloomberg
Dec-24-20 11:10AM	Top ETF of December & Its Best StocksZacks
Dec-23-20 07:29AM	12 Best Genomic Stocks to Buy NowInsider Monkey
08:37AM	Implied Volatility Surging for Pacific Biosciences (PACB) Stock OptionsZacks
Dec-18-20 04:05AM	Pacific Biosciences Grants Equity Incentive Award to New EmployeeGlobeNewswire
Dec-16-20 08:00AM	SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences TechnologyGlobeNewswire
Dec-14-20 08:00AM	Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi ReadsGlobeNewswire
Dec-10-20 10:02AM	Three High-Flying Biotech StocksFX Empire
Dec-09-20 12:04PM	Watch Out, Pacific Biosciences Stock Is Very ExtendedTheStreet.com
Dec-03-20 12:36PM	Should Value Investors Buy Pacific Biosciences of California (PACB) Stock?Insider Monkey
12:15PM	Why You Should Retain Pacific Biosciences (PACB) Stock NowZacks
Dec-02-20 11:30AM	Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue?Zacks
Nov-11-20 12:21PM	Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common StockGlobeNewswire
Nov-10-20 04:05AM	Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common StockGlobeNewswire
Nov-04-20 08:39AM	Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 LossZacks
Nov-03-20 06:15AM	Why Pacific Biosciences of California Hit a Speed Bump With Its Q3 ResultsMotley Fool
05:19AM	Are Institutions Heavily Invested In Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Shares?Simply Wall St.
Nov-03-20 04:02AM	Pacific Biosciences of California (PACB) Q3 2020 Earnings Call TranscriptMotley Fool
Nov-02-20 06:15AM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue EstimatesZacks
04:46AM	Pacific Biosciences: Q3 Earnings InsightsBenzinga
Nov-02-20 04:02AM	Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial ResultsGlobeNewswire
02:30AM	Pacific Biosciences of California, Inc. to Host Earnings CallACCESSWIRE
Oct-30-20 12:51PM	Medical Products Earnings Due on Nov 2: STE, HSIC & MoreZacks
Oct-26-20 12:31PM	Pacific Biosciences of California (PACB) Expected to Beat Earnings Estimates: Should You Buy?Zacks
Oct-22-20 08:00AM	Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy DiagnosticsGlobeNewswire
Oct-19-20 12:30PM	Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results CallGlobeNewswire
Oct-15-20 08:00AM	Children’s Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare DiseaseGlobeNewswire
Oct-08-20 11:30AM	Pacific Biosciences Unveils Sequel IIe for HiFi SequencingZacks
Oct-06-20 07:44AM	Hedge Funds Are Coming Back To Pacific Biosciences of California, Inc. (PACB)Insider Monkey
Oct-05-20 08:00AM	Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi SequencingGlobeNewswire
Oct-02-20 03:37AM	Why Pacific Biosciences of California Stock Jumped TodayMotley Fool
12:00PM	Are You Looking for a Top Momentum Pick? Why Pacific Biosciences of California (PACB) is a Great ChoiceZacks
Sep-23-20 08:59AM	Pacific Biosciences (PACB) Looks Good: Stock Adds 5.3% in SessionZacks
Sep-22-20 07:13AM	Pacific Biosciences' Shares March Higher, Can It Continue?Zacks
Sep-16-20 11:55AM	Illumina in talks to buy cancer testing startup Grail - Bloomberg NewsReuters
Sep-14-20 09:00AM	Pacific Biosciences Announces New Chief Financial OfficerGlobeNewswire
Sep-09-20 09:44AM	Benzinga's Top Upgrades, Downgrades For September 9, 2020Benzinga
Sep-02-20 11:30AM	Pacific Biosciences (PACB) Up 82.4% Since Last Earnings Report: Can It Continue?Zacks
Aug-18-20 08:43AM	Pacific Biosciences (PACB) Catches Eye: Stock Jumps 6.6%Zacks
Aug-12-20 12:51PM	Why Pacific Biosciences of California Shares Are Soaring TodayMotley Fool

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of Californ (PACB) Stock Discussions on Social Media

- PACB Stock on Twitter: https://twitter.com/search?q=$pacb
- PACB Stock on Reddit: https://www.reddit.com/search/?q=$pacb
- PACB Stock on SeekingAlpha: https://seekingalpha.com/symbol/PACB

More Discussions

Justin · January 16, 2021

Look at $pacb 6 month chart, yeah that’s pretty much what I’m expecting.

Upvote: 5 · Downvote: 0 · Replies: 0

Charlie67 · January 15, 2021

Sure glad I bought into ARKG and found PACB in the portfolio. PACB is so solid I just keep buying more every now and then as a good interest savings account.

Upvote: 4 · Downvote: 0 · Replies: 0

Edward · January 15, 2021

https://www.bio-itworld.com/news/2021/01/15/pacbio-year-of-expansion-whole-genome-clinical-goals

Upvote: 3 · Downvote: 0 · Replies: 0

DiverdanlikesBREW · January 15, 2021

I like the company and product But it is priced at what it should be 3 years from now. It was just over $4 less than a year ago. Have revenues and profit increased that much? To match the exponential gains it has made?

Upvote: 2 · Downvote: 0 · Replies: 0

RV · January 15, 2021

The ability of HiFi reads to detect genetic variants, even in hard-to-sequence regions of the genome, has already shown clinical utility.In a recent research collaboration with Invitae, announced in October 2020, the comprehensive, highly accurate reads were used to explore clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy.

Upvote: 2 · Downvote: 0 · Replies: 0

RV · January 15, 2021

The company boasts 90% storage reduction and 70-85% reduction in data analysis and a compute savings of $700 per genome. The platform opened doors to new customers, Henry said, who didn’t have the compute infrastructure or budgets for prior generations of PacBio sequencers.https://www.bio-itworld.com/news/2021/01/15/pacbio-year-of-expansion-whole-genome-clinical-goals

Upvote: 1 · Downvote: 2 · Replies: 0

KeNkKeL · January 15, 2021

they're trying to hold us back from $40, but I think we could break through past $40 today! then it's a blast off to $50!

Upvote: 2 · Downvote: 3 · Replies: 0

Stockguru · January 15, 2021

ARK sod more shares today. That’s 2 days in a row and it still went up! Yeah

Upvote: 1 · Downvote: 1 · Replies: 4

RV · January 15, 2021

All longs this is really a good one: 1. We should be doing genomic sequencing of the virus so that we know more about Covid variants in the U.S., @ashishkjha says. “We’ve got to get our act together and start doing this.” http://cnb.cx/3q0bXpShttps://twitter.com/i/status/13477058634448199682. [email protected]·Jan [email protected] hey PacBio, can you guys coordinate with federal virus task force to help with genetic sequencing of virus variants? Can the Sequel IIe system help here? #pacb #pacbio3. Andy [email protected]·22hThanks for asking it can and is being used by @h2so4hurts and the team @Labcorp for exactly that reason.4. Brian Krueger, [email protected] hard work pays off! Thanks @PacBio and @CDCgov , the 10 months of working through the details and collaborating behind the scenes has been a wild ride. Let's make some more genomes! https://labcorp.com/coronavirus-disease-covid-19/news/labcorp-awarded-cdc-contract-study-variants-covid-19-virus-and-improve-public-health-response5:29 PM · Jan 7, 2021·TweetDeck

Upvote: 3 · Downvote: 0 · Replies: 0

RV · January 14, 2021

Guys, esp. longs if you do not mind - I will share a tweet about how Pacbio HiFi sequencing is being tweaked to help scientists. I feel like I am hogging the MB. If you do not mind will post one. Let me know.

Upvote: 2 · Downvote: 4 · Replies: 0

RUEBEN · January 14, 2021

BNGO is gonna blow u guys outta the water. better product, picks up things PACB and invitae missed, there was a time this stock was 3$ too. Now its BNGOs turn!!

Upvote: 4 · Downvote: 0 · Replies: 0

RM · January 14, 2021

Phenomenal presentation by CH at the JP Morgan healthcare conference. Highlights:* Highest accuracy compared to other technologies with Hi-Fi* Strongest cash position in company history* Global commercial footprint expected to be 2-fold higher in 2021 - Australia, China, Japan etc..* Really hit hard on clinical applications.. A decade of development ready for clinical Impact now* w.r.t Invitae: One of the most exciting collaborations in the company history. Prices SUBSTANTIALLY below $1k; When CH joined the company he introduced PACB to his known customers including NVTA. They have technology in development together which are ready to be put to market soon..

Upvote: 8 · Downvote: 0 · Replies: 0

Albertus · January 14, 2021

I love Pacb but price to sales is over 70? We are pricing in a lot of future growth. Everyone loves PACB when its going up, but I remember when this was around 2 bucks..and not many to be found. Food for thought during the hype cycle.

Upvote: 1 · Downvote: 2 · Replies: 0

KeNkKeL · January 14, 2021

for those concerned that Ark sold PACB for the past few days, don't worry, I have noticed that Ark likes to keep PACB within the ~6.5% Weighted in ARKG and that's where it's at right now, if you check now it's right around that neighborhood, it's all part of their responsibility to maintain a certain level of exposure

Upvote: 1 · Downvote: 3 · Replies: 0

Short Master · January 14, 2021

Cathie Wood dumped PACB, she fancies a bit more of BNGO from now on. The romance between Cathie Wood and PACB lasted for 6 months, but now it's time to move on. Will take up BIG SHORT position on this stock tomorrow.

Upvote: 2 · Downvote: 2 · Replies: 6

RV · January 13, 2021

I have looked at holdings in ARKK and ARKG- and a lot of holdings in ARKK are in ARKG!We are in a period this field is going to take off. Look at other companies. I am waiting for Verve and Scribe Therapeutics to hit the market- Base Editors- BEAM is listed.

Upvote: 1 · Downvote: 3 · Replies: 0

DNA · January 13, 2021

I like how the NVTA partnership price point is "substantially lower than $1000". I think we all know where the Sequel IIe cost/genome is headed.....

Upvote: 5 · Downvote: 0 · Replies: 0

KeNkKeL · January 13, 2021

"This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc.

Upvote: 1 · Downvote: 3 · Replies: 0

chengis khan · January 13, 2021

https://finance.yahoo.com/m/ec393ed5-fd9e-3053-a6f5-fd019355801c/pacific-biosciences-reaches.html

Upvote: 13 · Downvote: 0 · Replies: 0

KeNkKeL · January 13, 2021

if anyone is curious about how much a Sequel II/e system costs, I did some back of the napkin math and figured out it's around $385,000 per machine based on this prelim earningshttps://finance.yahoo.com/news/pacific-biosciences-pacb-releases-preliminary-161504134.html

Upvote: 4 · Downvote: 1 · Replies: 0

Open in Yahoo | Open in Google | Open in Finviz